PON1 and metabolic dysfunction-associated steatohepatitis: Many in vivo and in vitro studies evaluated the impact of statins in NASH through various mechanisms, including their influence on pro-inflammatory factors, hepatic cells activation, sinusoidal endothelial cells, crown-like structures, PON1, PPARα, and GTPases modulation.